Following the release of its March quarter financial results, Bharat Petroleum Corporation Limited (BPCL) has become the subject of varied analyses from domestic and international brokerages. Analysts have issued target prices for the oil marketing company's (OMC) shares that span a wide spectrum, from a low of Rs 265 to a high of Rs 518 per share.
Brokerage Outlooks and Price Projections
Several prominent firms have weighed in on BPCL's future stock performance. MOFSL maintained a 'Neutral' rating, setting its target price at Rs 265, citing a weak near-term earnings outlook and increasing capital expenditure. Despite this, MOFSL acknowledged BPCL's strong Q4 performance, particularly its marketing margin, which significantly exceeded estimates.
Nuvama Institutional Equities revised its target price downwards to Rs 277 from Rs 322, reiterating a 'Reduce' recommendation. Nuvama's concerns stem from potential deterioration in peak earnings due to the West Asia conflict and rising LPG losses, alongside a high capex cycle expected to impact return ratios.
On the more optimistic end, Antique Stock Broking assigned the highest Street target at Rs 518. While anticipating an impact from elevated crude prices in the June quarter, Antique maintained a 'Buy' rating, projecting stable FY28 earnings and highlighting the importance of timely commissioning of key projects like Bina and Kochi petchem facilities.
Other Analyst Recommendations
- Emkay Global: Maintained a 'Buy' rating with a target of Rs 350, noting that BPCL's Q4 earnings surpassed estimates, though they lagged peers due to lower inventory gains.
- ICICI Securities: Maintained a 'Buy' rating with a target price of Rs 360.
- HDFC Securities: Valued the stock at Rs 367.
- UBS: Set a target price of Rs 365 for the OMC stock.
- CLSA: Valued the stock at Rs 270.
Brokerages emphasized various factors influencing their projections. MOFSL pointed to BPCL's superior Gross Refinery Margins (GRMs) due to optimized refinery production and crude procurement, including the capacity to process high-sulfur and Russian crude. However, it also flagged the weak near-term marketing outlook and the commencement of a new capex cycle as key concerns.
Nuvama specifically cut its FY27/28E Ebitda estimates, factoring in lower marketing margins and higher costs. Antique Stock Broking, despite its bullish long-term view, slashed FY27 Ebitda estimates by 49% due to expected crude price impacts but saw FY28 earnings remaining largely unchanged. They noted the delay of the Bina petchem project due to geopolitical issues but confirmed no cost escalation from management.
Key monitorables for investors include the timely commissioning of the Bina and Kochi petchem projects, along with the Mumbai RUF (Refinery Upgrade Facility) targeted for 2029, all of which are considered crucial drivers for future margins.